Notice of Proposed Sale · 144
Fulgent Genetics, Inc.
FLGTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- FULGENT GENETICS, INC.
- Issuer CIK
- 0001674930
- SEC file number
- 001-37894
- Phone
- 626-350-0537
- Person for whose account securities are to be sold
- Gao Hanlin
- Relationships to issuer
- Officer
- Street
- 4399 Santa Anita Ave
- City
- El Monte
- State / country code
- CA
- Postal code
- 91731
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 939 | 18,691.05 | 27,515,293 | 08/27/2026 | NASDAQ | Morgan Stanley Smith Barney LLC |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC
- Street
- 1 New York Plaza, 38th FL
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 02/26/2024 | Restricted stock vest | Fulgent Genetics, Inc. | 21,146 | N | 02/26/2024 | Equity compensation for services rendered |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Hanlin Gao | Common Stock | 05/27/2026 | 945 | 16,631.98 |
| Hanlin Gao | Common Stock | 06/02/2026 | 1,688 | 30,190.71 |
Seller — prior-sale row 1, entry 1
- Name
- Hanlin Gao
- Street
- C/O Fulgent Genetics, Inc.
- Street (continued)
- 4399 Santa Anita Avenue
- City
- El Monte
- State / country code
- CA
- Postal code
- 91731
Seller — prior-sale row 2, entry 1
- Name
- Hanlin Gao
- Street
- C/O Fulgent Genetics, Inc.
- Street (continued)
- 4399 Santa Anita Avenue
- City
- El Monte
- State / country code
- CA
- Postal code
- 91731
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Remarks
Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.
Notice signature
- Notice date
- 08/27/2026
- Signed
- /s/ Paul Kim as Attorney-In-Fact
Company context
Fulgent is a technology-based company with a well-established laboratory services business and a therapeutic development business. Fulgent’s laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Fulgent’s therapeutic development business is focused on developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The Company aims to transform from a diagnostic business into a fully integrated precision medicine company.